abortion pill

The abortion pill is often described as a “safe and effective way to end an early pregnancy,” at least according to Planned Parenthood. But is it? Recently, the Ethics and Public Policy Center released a study that analyzed insurance data codes for over 865,000 cases in which women took mifepristone (the abortion pill) and found that “serious adverse events” for the drug occurred at a rate approximately 22 times higher than the rate reported on the Food and Drug Administration’s (FDA) label for the drug.

A new, first-of-its-kind study asserts that serious adverse events from mifepristone, the first drug in the abortion pill regimen, occur at a rate approximately 22 times higher than the rate reported on the Food and Drug Administration’s (FDA) label for the drug.

The emergency room visitation rate for abortion complications appears to have increased since the U.S. Food and Drug Administration removed guardrails on the use of the abortion pill.

The study found that “women who visit emergency rooms after taking abortion pills are more likely to be seen for serious medical problems than their cohorts whose pregnancies end with surgical abortions or live births.”